肺内膜治疗改善了严重肺气患者的隔膜功能
Else A M D Ter Haar1,2, Dirk-Jan Slebos1,2, Jens T Bakker1,2
1University of Groningen, University Medical Centre Groningen, Department of Pulmonary Diseases, Groningen, The Netherlands.
ERJ open research
|May 13, 2025
概括
肺内膜 (EBV) 治疗通过减少肺部膨胀,改善严重肺气患者的隔膜功能. 这种干预有助于恢复隔膜力学和强度,提供潜在的治疗益处.
科学领域:
- 肺部病理学 肺部病理学
- 呼吸系统医学 呼吸系统医学
- 医疗器械 医疗器械
背景情况:
- 隔膜功能障碍在严重的肺气中很普遍,源于肺部过膨胀,损害了隔膜机制.
- 肺内膜 (EBV) 治疗是一种支气管镜干预措施,旨在减少高通胀.
研究的目的:
- 为了研究EBV治疗对严重肺气患者的隔膜功能的影响.
- 评估EBV治疗后隔膜运动,活动和强度的变化.
主要方法:
- 一项前性队列研究,涉及25名严重肺气患者.
- 用超声波来评估运动和加厚的隔膜功能,用表面电肌图 (sEMG) 来评估活动,用最大吸入压力来评估强度.
- 测量是在基线和EBV治疗后6周进行的.
主要成果:
- 在EBV治疗后,残留体积显著减少.
- 最大吸气压的显著增加,表明隔膜强度有所改善.
- 在呼吸过程中,隔膜运动和活动 (sEMG) 显著下降,这表明改善了机械和减少了精力.
结论:
- 在严重的肺气患者中,EBV治疗显著提高了隔膜功能.
- 这些发现突显了肺高通胀和隔膜功能障碍之间的直接生理联系.
- 通过EBV疗法减少高通胀可以部分逆转腹膜功能障碍.
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
144
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
144
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Chronic Obstructive Pulmonary Disease
1.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.1K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K
Breathing
56.7K
The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
56.7K
Acute Respiratory Failure-V
110
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
110


